BioCina PTY, Ltd.
BioCina is a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO) based in Australia, committed to providing industry-leading quality, reliability, and client-centric services. They specialize in process development, cGMP manufacturing, and regulatory compliance for a range of biopharmaceutical products including microbial, pDNA, mRNA, LNP, and drug products. With facilities in Adelaide and Perth, BioCina aims to accelerate therapies to market, offering strategic advantages such as tax incentives, regulatory efficiency, and advanced infrastructure to support global biomanufacturing success.
Industries
Nr. of Employees
medium (51-250)
Products
Microbial biologics manufacturing
Bacterial protein expression platforms and manufacturing support for microbial biologics, including whole-cell vaccine production.
Plasmid DNA (pDNA) development and supply
Process development and bulk cGMP production of plasmids for vaccines, cell and gene therapies and as templates for mRNA manufacture.
mRNA development and manufacturing
mRNA manufacturing services covering preclinical, toxicology, clinical and commercial stages for therapeutic and vaccine applications.
Lipid nanoparticle (LNP) encapsulation
LNP formulation and encapsulation services to deliver nucleic acid payloads for preclinical and clinical applications.
Sterile drug product development and fill–finish
Development, formulation and analytical services for sterile liquid injectables plus clinical and commercial fill–finish capabilities.
Microbial biologics manufacturing
Bacterial protein expression platforms and manufacturing support for microbial biologics, including whole-cell vaccine production.
Plasmid DNA (pDNA) development and supply
Process development and bulk cGMP production of plasmids for vaccines, cell and gene therapies and as templates for mRNA manufacture.
mRNA development and manufacturing
mRNA manufacturing services covering preclinical, toxicology, clinical and commercial stages for therapeutic and vaccine applications.
Lipid nanoparticle (LNP) encapsulation
LNP formulation and encapsulation services to deliver nucleic acid payloads for preclinical and clinical applications.
Sterile drug product development and fill–finish
Development, formulation and analytical services for sterile liquid injectables plus clinical and commercial fill–finish capabilities.
Services
Technology transfer
Standardised tech transfer procedures with dedicated project management and quality oversight to support process handover and scale-up.
Process development
End-to-end process design and optimisation for upstream and downstream workflows across microbial biologics, plasmid DNA, mRNA, LNP and sterile injectables.
Analytical development
Method transfer, development, qualification and validation services supporting preclinical through commercial stages for varied modalities.
cGMP manufacturing
Flexible, phase-appropriate GMP manufacturing from preclinical to commercial for microbial biologics, pDNA, mRNA, LNP and sterile injectables across multiple manufacturing sites.
Quality and regulatory support
Quality management and regulatory submission support aligned to major global regulators, including inspection readiness and clinical-trial regulatory guidance.
Technology transfer
Standardised tech transfer procedures with dedicated project management and quality oversight to support process handover and scale-up.
Process development
End-to-end process design and optimisation for upstream and downstream workflows across microbial biologics, plasmid DNA, mRNA, LNP and sterile injectables.
Analytical development
Method transfer, development, qualification and validation services supporting preclinical through commercial stages for varied modalities.
cGMP manufacturing
Flexible, phase-appropriate GMP manufacturing from preclinical to commercial for microbial biologics, pDNA, mRNA, LNP and sterile injectables across multiple manufacturing sites.
Quality and regulatory support
Quality management and regulatory submission support aligned to major global regulators, including inspection readiness and clinical-trial regulatory guidance.
Expertise Areas
- cGMP biologics manufacturing
- Process development and scale-up
- Technology transfer
- Analytical development and validation
Key Technologies
- mRNA manufacturing
- Plasmid DNA (pDNA) manufacturing
- Minicircle DNA production
- Lipid nanoparticle (LNP) encapsulation